Class II Correction Study Using the Invisalign System

NCT ID: NCT02376829

Last Updated: 2023-05-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2021-11-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate that growing teenagers which present up to full cusp Class II malocclusions can be treated using the Invisalign System.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Invisalign® System consists of a series of clear plastic aligners that are intended to replace conventional wire and bracket technology for many orthodontic cases. Each custom manufactured aligner exerts gentle, continuous forces to move teeth incrementally from their original state to a final, treated state. Each aligner is worn for about two weeks, then replaced by the next in the series until the final position is achieved. For years, orthodontists and dentists have used removable appliances for orthodontic treatment. Today, with the application of computer technology and custom manufacturing, Invisalign treats a broader range of cases with greater precision.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malocclusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The Invisalign System

Class II correction of malocclusions

Group Type EXPERIMENTAL

Invisalign System

Intervention Type DEVICE

The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Invisalign System

The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must have fully erupted dentition excluding 2nd and 3rd molars
* Age range 11-19 years old
* Subject that requires bilateral Class II correction and must require at least 3mm of correction as measured by first molar relationship

Exclusion Criteria

* Subject who has unerupted, erupting, partially erupted dentition (except for 2nd and 3rd molars)
* Subject who has spaces between adjacent teeth larger than 3mm
* Subject with active caries
* Subject with periodontal disease
* Subject does not have at least 1st molar fully captured in PVS (polyvinyl siloxane material ) impression or intraoral scan.
* Subject with TMD (Temporomandibular joint dysfunction) symptoms
* Subject has undergone pre-treatment with any orthodontic appliance (any previous treatment prior to study)
* Subject has known allergy to latex and plastic
* Subjects who are pregnant or will become pregnant during treatment
Minimum Eligible Age

11 Years

Maximum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Align Technology, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sherri Wilson-Lopes

Role: STUDY_DIRECTOR

Align Technology, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Gary Brigham

Scottsdale, Arizona, United States

Site Status

Dr. Donna Galante

Rocklin, California, United States

Site Status

Dr. Mark Holt

Roseville, California, United States

Site Status

Dr. Ray Kubisch and Dr. Drew Ferris

Santa Barbara, California, United States

Site Status

Dr. Sandra Selnick

Ellicott City, Maryland, United States

Site Status

Dr. Regina Blevins

Inver Grove Heights, Minnesota, United States

Site Status

Dr. William Kottemann

Maple Grove, Minnesota, United States

Site Status

Dr. Barry Glaser

Cortlandt Manor, New York, United States

Site Status

Dr. Sam Daher

Vancouver, British Columbia, Canada

Site Status

Dr. Sandra Tai

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MRF-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Primer Aligner Study
NCT02550938 COMPLETED NA